What does Bioptik Technology Incorporation do?

Bioptik Technology Incorporation (4161.TWO) operates in the Medical - Devices industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 4161.TWO's market cap?

Bioptik Technology Incorporation (4161.TWO) has a market capitalization of approximately $1.38 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 4161.TWO pay a dividend?

Yes — Bioptik Technology Incorporation (4161.TWO) pays a dividend annually, with a trailing-twelve-month yield of 3.03%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

4161.TWO

Bioptik Technology Incorporation

TWO·Medical, Devices · Healthcare

NT$23.10NT$0.10+0.43%

Market capNT$1.38B·Market closed·Aug 26 3:16 AM UTC

Price Chart

NT$23.10+NT$0.10 (+0.43%)today

+0.57%CAGR +0.11%

Select date range

FromTo

Jul 29, 2011Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)3.03%

Annual Dividend (FWD)NT$0.70

Dividend Growth (5Y)+4.1%

Dividend Safety—

Payout Ratio55.4%

FCF Payout Ratio122.3%

Most Recent DividendNT$0.700

Ex-Dividend DateJul 16

Payment DateAug 14

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)+47.6%

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMar 18

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$912.86M

Net IncomeNT$108.09M

Net Margin11.8%

Operating Cash FlowNT$51.05M

Capital ExpendituresNT$18.15M

Free Cash FlowNT$32.90M

Return on Equity10.9%

Return on Invested Capital0.9%

Net DebtNT$25.23M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 4161.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 4161.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 4161.TWO and 80,000+ other tickers.

About Bioptik Technology Incorporation

Bioptik Technology Incorporation operates as a global entity, focusing on the creation and distribution of medical instruments and diagnostic chemicals. The company's product line encompasses the EasyMate series of blood glucose monitoring systems, as well as comprehensive diagnostic devices designed to measure blood glucose, cholesterol, and uric acid levels, complete with their essential test strips. Beyond its healthcare offerings, Bioptik also provides a range of skincare solutions, including those formulated with hyaluronic acid, alongside various dietary supplements. Uniquely, the…

CEO: Jin-Chang Yang
Sector: Healthcare
Industry: Medical - Devices
Exchange: TWO
Employees: 80
Website: www.bioptik.com.tw

Peers

Peers Tab

6730.TWO

Lagis Enterprise Co., Ltd.

Perfect Medical Industry Co., Ltd.

Cap

NT$1.0B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 4161.TWO

What does Bioptik Technology Incorporation do?: Bioptik Technology Incorporation (4161.TWO) operates in the Medical - Devices industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 4161.TWO's market cap?: Bioptik Technology Incorporation (4161.TWO) has a market capitalization of approximately $1.38 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 4161.TWO pay a dividend?: Yes — Bioptik Technology Incorporation (4161.TWO) pays a dividend annually, with a trailing-twelve-month yield of 3.03%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.